Amlin PLC
1 November 2002
PRESS RELEASE
For Immediate Release
1 November 2002
AMLIN INCREASES DEBT FACILITY
Amlin is pleased to announce the renewal and extension of its debt facilities to
support its underwriting plans for 2003.
State Farm will continue to provide support through its letter of credit
facility of $130 million.
In addition Amlin has renewed and extended its bank facilities which also
provide letters of credit to support its underwriting activities. These
facilities have been increased from £39 million to £60 million, and are
available for the next two underwriting years.
The banking facilities were arranged by Lloyds TSB Capital Markets (acting also
as Agent) and provided by Barclays Bank plc, Commerzbank AG and Lloyds TSB Bank
Plc
Enquiries:
Richard Hextall, Amlin plc 0207 746 1000
David Haggie, Haggie Financial Limited 0207 417 8989
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.